The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Amyotrophic Lateral Sclerosis: A Focus on Disease Progression
Open accessAbstract
Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a neurodegenerative disease in which motor neuron death is induced, a wide range of biomarkers have been selected to identify therapeutic targets. ALS shares altered molecular pathways with other neurodegenerative diseases, such as Alzheimer’s, Huntington’s, and Parkinson’s diseases. However, the molecular targets that directly influence its aggressive nature remain unknown. What is the first link in the neurodegenerative chain of ALS that makes this disease so peculiar? In this review, we will discuss the progression of the disease from the viewpoint of the potential biomarkers described to date in human and animal model samples. Finally, we will consider potential therapeutic strategies for ALS treatment and future, innovative perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Electrodiagnostic criteria for diagnosis of ALS
de Carvalho, M., Dengler, R., Eisen, A., England, J. D., Kaji, R., Kimura, J., Mills, K., Mitsumoto, H., Nodera, H., Shefner, J., et al. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.09.143 · Cited by 1,194
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Prevalence and patterns of cognitive impairment in sporadic ALS
Ringholz, G. M., Appel, S. H., Bradshaw, M., Cooke, N. A., Mosnik, D. M., & Schulz, P. E. (2005) · Neurology · doi:10.1212/01.wnl.0000172911.39167.b6 · Cited by 844
Are amyotrophic lateral sclerosis patients cognitively normal?
Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J. H., Olney, R. K., & Miller, B. (2003) · Neurology · doi:10.1212/01.wnl.0000055861.95202.8d · Cited by 620
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., Carmeliet, P., & Mazarakis, N. D. (2004) · Nature · doi:10.1038/nature02544 · Cited by 590
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Vucic, S., Nicholson, G. A., & Kiernan, M. C. (2008) · Brain · doi:10.1093/brain/awn071 · Cited by 460
Wijesekera, L. C., & Nigel Leigh, P. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-3 · Cited by 442
Suzuki, M., McHugh, J., Tork, C., Shelley, B., Klein, S. M., Aebischer, P., & Svendsen, C. N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000689 · Cited by 311
Glass, J. D., Boulis, N. M., Johe, K., Rutkove, S. B., Federici, T., Polak, M., Kelly, C., & Feldman, E. L. (2012) · STEM CELLS · doi:10.1002/stem.1079 · Cited by 295
Reduced oxidative damage in ALS by high‐dose enteral melatonin treatment
Weishaupt, J. H., Bartels, C., Pölking, E., Dietrich, J., Rohde, G., Poeggeler, B., Mertens, N., Sperling, S., Bohn, M., Hüther, G., et al. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00377.x · Cited by 282
Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis
Menzies, F. M. (2002) · Brain · doi:10.1093/brain/awf167 · Cited by 277
AP-HP, H. D. L. P.-S., & Gordon, P. (2013) · Aging and Disease · doi:10.14336/ad.2013.0400295 · Cited by 277
Awaji Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis: A Systematic Review
Costa, J., Swash, M., & de Carvalho, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.254 · Cited by 249
Almer, G., Vukosavic, S., Romero, N., & Przedborski, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722415.x · Cited by 231
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
Karnezis, T., Mandemakers, W., McQualter, J. L., Zheng, B., Ho, P. P., Jordan, K. A., Murray, B. M., Barres, B., Tessier-Lavigne, M., & Bernard, C. C. A. (2004) · Nature Neuroscience · doi:10.1038/nn1261 · Cited by 230
Feldman, E. L., Boulis, N. M., Hur, J., Johe, K., Rutkove, S. B., Federici, T., Polak, M., Bordeau, J., Sakowski, S. A., & Glass, J. D. (2014) · Annals of Neurology · doi:10.1002/ana.24113 · Cited by 227
Amyotrophic lateral sclerosis in an urban setting: A population based study of inner city London
Johnston, C. A., Stanton, B. R., Turner, M. R., Gray, R., Blunt, A. H.-M., Butt, D., Ampong, M.-A., Shaw, C. E., Leigh, P. N., & Al-Chalabi, A. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0195-y · Cited by 215
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis
Ranganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V., Lacomis, D., Urbinelli, L., Newhall, K., Cudkowicz, M. E., Brown, R. H., & Bowser, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03478.x · Cited by 212
Oxidative stress induced by glutamate receptor agonists
Bondy, S. C., & Lee, D. K. (1993) · Brain Research · doi:10.1016/0006-8993(93)91405-h · Cited by 211
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis
Chiò, A., Hammond, E. R., Mora, G., Bonito, V., & Filippini, G. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306589 · Cited by 206
Kiaei, M., Kipiani, K., Petri, S., Chen, J., Calingasan, N. Y., & Beal, M. F. (2005) · Neurodegenerative Diseases · doi:10.1159/000090364 · Cited by 199
Assessment of cortical excitability using threshold tracking techniques
Vucic, S., Howells, J., Trevillion, L., & Kiernan, M. C. (2006) · Muscle & Nerve · doi:10.1002/mus.20481 · Cited by 190
Kiaei, M., Petri, S., Kipiani, K., Gardian, G., Choi, D.-K., Chen, J., Calingasan, N. Y., Schafer, P., Muller, G. W., Stewart, C., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5253-05.2006 · Cited by 182
Mechanisms of neurodegeneration in amyotrophic lateral sclerosis: Figure 1
Cluskey, S., & Ramsden, D. B. (2001) · Molecular Pathology · doi:10.1136/mp.54.6.386 · Cited by 182
Nogo Provides a Molecular Marker for Diagnosis of Amyotrophic Lateral Sclerosis
Dupuis, L., Gonzalez de Aguilar, J.-L., di Scala, F., Rene, F., de Tapia, M., Pradat, P.-F., Lacomblez, L., Seihlan, D., Prinjha, R., Walsh, F. S., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0522 · Cited by 172
Genetics of sporadic amyotrophic lateral sclerosis
Schymick, J. C., Talbot, K., & Traynor, B. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm215 · Cited by 169
Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat
Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., & Pochet, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.018 · Cited by 168
Petri, S., Kiaei, M., Damiano, M., Hiller, A., Wille, E., Manfredi, G., Calingasan, N. Y., Szeto, H. H., & Beal, M. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04018.x · Cited by 166
Lower serum lipid levels are related to respiratory impairment in patients with ALS
Chiò, A., Calvo, A., Ilardi, A., Cavallo, E., Moglia, C., Mutani, R., Palmo, A., Galletti, R., Marinou, K., Papetti, L., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c1df1e · Cited by 165
Self-citationIdentification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis
Figueroa-Romero, C., Hur, J., Bender, D. E., Delaney, C. E., Cataldo, M. D., Smith, A. L., Yung, R., Ruden, D. M., Callaghan, B. C., & Feldman, E. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052672 · Cited by 161
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale
Balendra, R., Jones, A., Jivraj, N. K., Knights, C., Ellis, C. M., Burman, R., Turner, M. R., Leigh, P. N., Shaw, C. E., & Al‐Chalabi, A. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.897357 · Cited by 151
Corti, S. P., Locatelli, F., Papadimitriou, D. A., Bo, R. D., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Fortunato, F., Strazzer, S., et al. (2007) · Brain · doi:10.1093/brain/awm043 · Cited by 137
Peviani, M., Salvaneschi, E., Bontempi, L., Petese, A., Manzo, A., Rossi, D., Salmona, M., Collina, S., Bigini, P., & Curti, D. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.010 · Cited by 136
Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro
Zurn, A. D., Winkel, L., Menoud, A., Djabali, K., & Aebischer, P. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960415)44:2<133::aid-jnr5>3.0.co;2-e · Cited by 136
Chancellor, A. M., Slattery, J. M. A., Fraser, H., Swingler, R. J., Holloway, S. M., & Warlow, C. P. (1993) · Journal of Neurology · doi:10.1007/bf00839964 · Cited by 135
Genetic counselling in ALS: facts, uncertainties and clinical suggestions
Chiò, A., Battistini, S., Calvo, A., Caponnetto, C., Conforti, F. L., Corbo, M., Giannini, F., Mandrioli, J., Mora, G., Sabatelli, M., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305546 · Cited by 133
Self-citationNogo expression in muscle correlates with amyotrophic lateral sclerosis severity
Jokic, N., de Aguilar, J. G., Pradat, P., Dupuis, L., Echaniz‐Laguna, A., Müller, A., Dubourg, O., Seilhean, D., Hauw, J., Loeffler, J., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20420 · Cited by 131
Graber, D. J., Hickey, W. F., & Harris, B. T. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-8 · Cited by 130
Boylan, K., Yang, C., Crook, J. E., Overstreet, K., Heckman, M. G., Wang, Y., Borchelt, D., & Shaw, G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06386.x · Cited by 121
Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment
Goodall, G., & Morrison, K. E. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010854 · Cited by 119
Lincecum, J. M., Vieira, F. G., Wang, M. Z., Thompson, K., Zutter, G. S. D., Kidd, J. D., Moreno, A., Sànchez, R., Carrion, I. J., Levine, B. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.557 · Cited by 119
Multi-Parametric Spinal Cord MRI as Potential Progression Marker in Amyotrophic Lateral Sclerosis
Mendili, M. E., Cohen‐Adad, J., Pélégrini‐Issac, M., Rossignol, S., Morizot-Koutlidis, R., Marchand‐Pauvert, V., Iglesias, C., Sangari, S., Katz, R., Lehéricy, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095516 · Cited by 117
Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis
Vucic, S., & Kiernan, M. C. (2009) · Current Molecular Medicine · doi:10.2174/156652409787847173 · Cited by 113
Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?
Pinto, A. C., Alves, M., Nogueira, A., Evangelista, T., Carvalho, J., Coelho, A., de Carvalho, M. A., & Sales-Luis, M. L. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00218-x · Cited by 104
Keller, A. F., Gravel, M., & Križ, J. (2008) · Glia · doi:10.1002/glia.20836 · Cited by 95
Su, X., Broach, J. R., Connor, J. R., Gerhard, G. S., & Simmons, Z. (2014) · Muscle & Nerve · doi:10.1002/mus.24198 · Cited by 94
Kalra, S., Genge, A. L., & Arnold, D. L. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310006689 · Cited by 93
Gerber, Y. N., Sabourin, J.-C., Rábano, M., Vivanco, M. D., & Perrin, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036000 · Cited by 85
Microglial Upregulation of Progranulin as a Marker of Motor Neuron Degeneration
Philips, T., Muynck, L. D., Thu, H. N. T., Weynants, B., Vanacker, P., Dhondt, J., Sleegers, K., Schelhaas, H. J., Verbeek, M. M., Vandenberghe, R. R., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181fc9aea · Cited by 85
Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo
Mennini, T., Paola, M. D., Bigini, P., Mastrotto, C., Fumagalli, E. R., Barbera, S., Mengozzi, M., Viviani, B., Corsini, E., Marinovich, M., et al. (2006) · Molecular Medicine · doi:10.2119/2006-00045.mennini · Cited by 84
Shin, J. H., Cho, S. I., Lim, H. R., Lee, J. K., Lee, Y. A., Noh, J. S., Joo, I. S., Kim, K.-W., & Gwag, B. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030676 · Cited by 74
Genetic Biomarkers for ALS Disease in Transgenic SOD1G93A Mice
Calvo, A. C., Manzano, R., Atencia-Cibreiro, G., Oliván, S., Muñoz, M. J., Zaragoza, P., Cordero-Vázquez, P., Esteban‐Pérez, J., García‐Redondo, A., & Osta, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032632 · Cited by 66
Self-citationFas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice
Locatelli, F., Corti, S. P., Papadimitriou, D. A., Fortunato, F., Bo, R. D., Donadoni, C., Nizzardo, M., Nardini, M., Salani, S., Ghezzi, S., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21152 · Cited by 63
Zhao, Z., Lange, D. J., Ho, L., Bonini, S. A., Shao, B., Salton, S. R., Thomas, S., & Pasinetti, G. M. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.92 · Cited by 61
Rusina, R., Ridzoň, P., Kulišťák, P., Keller, O., Bartoš, A., Buncová, M., Fialová, L., Koukolík, F., & Matěj, R. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02717.x · Cited by 59
Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy
Moreno‐Igoa, M., Calvo, A. C., Penas, C., Manzano, R., Oliván, S., Muñoz, M. J., Mancuso, R., Zaragoza, P., Aguilera, J., Navarro, X., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0556-y · Cited by 55
Self-citationPetri, S., Calingasan, N. Y., Alsaied, O. A., Wille, E., Kiaei, M., Friedman, J. E., Baranova, O., Chavez, J. C., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04604.x · Cited by 55
Pichon, C. E. L., Domínguez, S. L., Solanoy, H. O., Ngu, H., Lewin‐Koh, N., Chen, M., Eastham‐Anderson, J., Watts, R. J., & Scearce-Levie, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062342 · Cited by 52
Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases
Katsuno, M., Tanaka, F., & Sobue, G. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301307 · Cited by 52
A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model
Ciriza, J., Moreno‐Igoa, M., Calvo, A. C., Yagüe, G., Palacio, J., Miana-Mena, F. J., Muñoz, M. J., Zaragoza, P., Brûlet, P., & Pinzolas, R. O. (2008) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2008-00428 · Cited by 41
Self-citationAmyotrophic Lateral Sclerosis from Bench to Bedside
Lomen‐Hoerth, C. (2008) · Seminars in Neurology · doi:10.1055/s-2008-1062265 · Cited by 39
Makki, A. A., & Benatar, M. G. (2007) · Muscle & Nerve · doi:10.1002/mus.20748 · Cited by 37
T 2 -Weighted MRI Detects Presymptomatic Pathology in the SOD1 Mouse Model of ALS
Evans, M. C., Serres, S., Khrapitchev, A. A., Stolp, H. B., Anthony, D. C., Talbot, K., Turner, M. R., & Sibson, N. R. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.19 · Cited by 37
Choi, C., Lee, Y., Kim, H., Kim, S. H., Kim, S., & Kim, S. (2013) · Cell Transplantation · doi:10.3727/096368912x637019 · Cited by 37
Hays, A. P., Hays, A. P., Roxas, A., Vallejos, H. A., DʼAgati, V., Torres, R., Sadiq, S. A., Thomas, F. P., Bailey-Braxton, D., Rowland, L. P., et al. (1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199007000-00003 · Cited by 33
Zhang, X., Chen, S., Li, L., Wang, Q., & Le, W. D. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.02.024 · Cited by 33
Fujita, K., Honda, M., Hayashi, R., et al. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00088-4 · Cited by 32
Cifra, A., Nani, F., & Nistri, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07579.x · Cited by 31
Applying proteomics to the diagnosis and treatment of ALS and related diseases
Bowser, R. P., & Lacomis, D. (2009) · Muscle & Nerve · doi:10.1002/mus.21488 · Cited by 29
Obayashi, K., Sato, K., Shimazaki, R., Ishikawa, T., Goto, K., Ueyama, H., Mori, T., Ando, Y., & Kumamoto, T. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1278 · Cited by 28
Soon, C. P. W., Crouch, P. J., Turner, B. J., McLean, C., Laughton, K. M., Atkin, J. D., Masters, C. L., White, A. R., & Li, Q.-X. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.11.015 · Cited by 26
Bigini, P., Repici, M., Cantarella, G., Fumagalli, E. R., Barbera, S., Cagnotto, A., Luigi, A. D., Tonelli, R., Bernardini, R., Borsello, T., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.005 · Cited by 26
Jones, A. R., Woollacott, I., Shatunov, A., Cooper‐Knock, J., Buchman, V. L., Sproviero, W., Smith, B. N., Scott, K. M., Balendra, R., Abel, O., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.003 · Cited by 26
Benkler, C., Offen, D., Melamed, E., Kupershmidt, L., Amit, T., Mandel, S. A., Youdim, M. B. H., & Weinreb, O. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0026-1 · Cited by 22
Reticulons as Markers of Neurological Diseases: Focus on Amyotrophic Lateral Sclerosis
Fergani, A., Dupuis, L., Jokic, N., Larmet, Y., de Tapia, M., René, F., Loeffler, J., & de Aguilar, J. G. (2005) · Neurodegenerative Diseases · doi:10.1159/000089624 · Cited by 17
Gerber, Y. N., Privat, A., & Perrin, F. E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00280 · Cited by 16
Shinozawa, T., Urade, Y., Maruyama, T., & Watabe, D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.045 · Cited by 10
Goodall, G. (2006) · Teaching Statistics · doi:10.1111/j.1467-9639.2006.00001.x · Cited by 2
Cited by
Wearable and flexible electronics for continuous molecular monitoring
Yang, Y., & Gao, W. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00730b · Cited by 1,315
Wearable sensors for monitoring the physiological and biochemical profile of the athlete
Seshadri, D. R., Li, R. T., Voos, J. E., Rowbottom, J. R., Alfes, C. M., Zorman, C. A., & Drummond, C. K. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0150-9 · Cited by 537
Drought Stress in Plants: Causes, Consequences, and Tolerance
Salehi-Lisar, S. Y., & Bakhshayeshan-Agdam, H. (2016) · Drought Stress Tolerance in Plants, Vol 1 · doi:10.1007/978-3-319-28899-4_1 · Cited by 339
Cowpea: an overview on its nutritional facts and health benefits
Jayathilake, C., Visvanathan, R., Deen, A., Bangamuwage, R., Jayawardana, B. C., Nammi, S., & Liyanage, R. (2018) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.9074 · Cited by 336
Gut microbiota changes in the extreme decades of human life: a focus on centenarians
Santoro, A., Ostan, R., Candela, M., Biagi, E., Brigidi, P., Capri, M., & Franceschi, C. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2674-y · Cited by 250
Metadata
- Authors
- Calvo, A. C., Manzano, R., Mendonça, D. M. F., Muñoz, M. J., Zaragoza, P., & Osta, R.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-12
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W1991716304
- Cited by
- 403
- References
- 81
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.